bioAffinity Technologies, Inc. (NAS: BIAF) Stock Analysis & Fundamentals | ScreenerHero

Create free account

BIAFbioAffinity Technologies, Inc.

NAS · US · Healthcare · Diagnostics & Research · bioaffinitytech.com

0.7118USD-1.47%Mkt Cap: 4.47M $P/E: —1d ago

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United Sta…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.85BUSDP/E 44.2

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.06BUSDP/E 27.3

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 21.6

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.75BUSDP/E 26.5

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.64BUSDP/E 41.7

Personalis, Inc.

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Clínica Baviera, S.A.

$1.02BUSDP/E 21.4

OPKO Health, Inc.

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$293.12MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

Leveljump Healthcare Corp.

Prostatype Genomics AB (publ)

Telo Genomics Corp.

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap4.47M $

Enterprise Value1.56M $

Revenue (TTM)5.66M $

Gross Profit1.88M $

Net Income (TTM)-14.91M $

Revenue/Share2.089 USD

Last Price0.7118 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees57

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-1.19

PEG—

EV/EBITDA-0.14

EV/Revenue0.28

P/S0.79

P/B0.87

EPS (TTM)-4.67

EPS (Forward)-0.60

52W Range

0.61211% of range13.50

52W High13.50 USD

52W Low0.6121 USD

Profitability

Gross Margin30.80%

Oper. Margin-267.62%

EBITDA Margin-196.07%

Profit Margin-244.10%

ROE-204.87%

ROA-136.03%

Growth

Revenue Growth-27.10%

Earnings Growth—

Cash Flow & Leverage

Operating CF-9.33M $

CapEx (TTM)60.57K $

FCF Margin-108.56%

FCF Yield-137.39%

Net Debt-1.72M $

Net Debt/EBITDA0.15

Balance Sheet

Debt/Equity0.16

Current Ratio1.36

Quick Ratio1.19

Book Value/Sh0.8150 USD

Cash/Share0.6840 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Splits

Last Split1:30

Split DateSep 19, 2025

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.6.28M

Float4.42M

Insiders2.29%

Institutions6.44%

Short Interest

Short Ratio1.5d

Short % Float13.18%

Short % Out.13.00%

Shares Short816.64K

Short (prev mo.)445.10K

Technical

SMA 501.376 (-48.3%)

SMA 2001.860 (-61.7%)

Beta-1.11

S&P 52W Chg20.25%

Avg Vol (30d)511.02K

Avg Vol (10d)598.41K

Technical Indicators

RSI (14)26.8

MACD-0.2027

MACD Signal-0.2301

MACD Hist.+0.0274

BB Upper0.9243 USD

BB Middle0.8052 USD

BB Lower0.6860 USD

BB Width29.59%

ATR (14)0.0975 USD

Vol Ratio (20d)0.11x